Found: 52
Select item for more details and to access through your institution.
Liquid‐based endometrial cytology using SurePath™ is not inferior to suction endometrial tissue biopsy for detecting endometrial malignancies: Midterm report of a multicentre study advocated by Japan Association of Obstetricians and Gynecologists
- Published in:
- Cytopathology, 2019, v. 30, n. 2, p. 223, doi. 10.1111/cyt.12657
- By:
- Publication type:
- Article
Effects of leptin on gonadotropin secretion in juvenile female rat pituitary cells.
- Published in:
- European Journal of Endocrinology, 2002, v. 146, n. 2, p. 261, doi. 10.1530/eje.0.1460261
- By:
- Publication type:
- Article
What information can change the attitude of teachers toward the human papillomavirus vaccine?
- Published in:
- Journal of Obstetrics & Gynaecology Research, 2018, v. 44, n. 4, p. 778, doi. 10.1111/jog.13584
- By:
- Publication type:
- Article
Glasgow Prognostic Score (GPS) and Tumor Response as Biomarkers of Nivolumab Monotherapy in Third-or-Later-line Setting for Advanced Gastric Cancer.
- Published in:
- In Vivo, 2020, v. 34, n. 4, p. 1921, doi. 10.21873/invivo.11989
- By:
- Publication type:
- Article
Argon plasma coagulation for treatment of hemorrhagic radiation gastroduodenitis.
- Published in:
- Digestive Endoscopy, 2002, v. 14, n. 1, p. 5, doi. 10.1046/j.1443-1661.2002.00154.x
- By:
- Publication type:
- Article
Plasma Exchange in a Patient with Postpartum HELLP Syndrome.
- Published in:
- Journal of Obstetrics & Gynaecology Research, 1996, v. 22, n. 4, p. 371, doi. 10.1111/j.1447-0756.1996.tb00991.x
- By:
- Publication type:
- Article
Primary tumor location as a predictor of survival in patients with RAS wild-type colorectal cancer who receive molecularly targeted drugs as first-line therapy: a multicenter real-world observational study by the Japanese Society for Cancer of the Colon and Rectum
- Published in:
- International Journal of Clinical Oncology, 2022, v. 27, n. 9, p. 1450, doi. 10.1007/s10147-022-02208-7
- By:
- Publication type:
- Article
Randomized phase II study of CPT-11 versus PTX versus each combination chemotherapy with S-1 for advanced gastric cancer that is refractory to S-1 or S-1 plus CDDP: OGSG0701.
- Published in:
- International Journal of Clinical Oncology, 2021, v. 26, n. 10, p. 1871, doi. 10.1007/s10147-021-01984-y
- By:
- Publication type:
- Article
Comparison of S-1–cisplatin every 5 weeks with capecitabine-cisplatin every 3 weeks for HER2-negative gastric cancer (recurrent after S-1 adjuvant therapy or chemotherapy-naïve advanced): pooled analysis of HERBIS-2 (OGSG 1103) and HERBIS-4A (OGSG 1105) trials
- Published in:
- International Journal of Clinical Oncology, 2020, v. 25, n. 9, p. 1635, doi. 10.1007/s10147-020-01711-z
- By:
- Publication type:
- Article
A phase II study of 5-fluorouracil/L-leucovorin/oxaliplatin (mFOLFOX6) in Japanese patients with metastatic or unresectable small bowel adenocarcinoma.
- Published in:
- International Journal of Clinical Oncology, 2017, v. 22, n. 5, p. 905, doi. 10.1007/s10147-017-1138-6
- By:
- Publication type:
- Article
Relationship of BRAF mutation, morphology, and apoptosis in early colorectal cancer.
- Published in:
- International Journal of Colorectal Disease, 2008, v. 23, n. 1, p. 7, doi. 10.1007/s00384-007-0349-0
- By:
- Publication type:
- Article
Diagnostic significance of gently sloping depression and irregular margin in superficial elevated colorectal tumors.
- Published in:
- International Journal of Colorectal Disease, 2007, v. 22, n. 1, p. 25, doi. 10.1007/s00384-006-0115-8
- By:
- Publication type:
- Article
Excessive alcohol intake enhances the development of synchronous cancerous lesion in colorectal cancer patients.
- Published in:
- International Journal of Colorectal Disease, 2004, v. 19, n. 2, p. 171, doi. 10.1007/s00384-003-0516-x
- By:
- Publication type:
- Article
Combined Analysis of Plasma Amphiregulin and Heregulin Predicts Response to Cetuximab in Metastatic Colorectal Cancer.
- Published in:
- PLoS ONE, 2015, v. 10, n. 11, p. 1, doi. 10.1371/journal.pone.0143132
- By:
- Publication type:
- Article
Extended RAS and BRAF Mutation Analysis Using Next-Generation Sequencing.
- Published in:
- PLoS ONE, 2015, v. 10, n. 5, p. 1, doi. 10.1371/journal.pone.0121891
- By:
- Publication type:
- Article
Risk Factors for Cisplatin-Induced Nephrotoxicity and Potential of Magnesium Supplementation for Renal Protection.
- Published in:
- PLoS ONE, 2014, v. 9, n. 7, p. 1, doi. 10.1371/journal.pone.0101902
- By:
- Publication type:
- Article
Effect of the mutation (C3435T) at exon 26 of the MDR1 gene on expression level of MDR1 messenger ribonucleic acid in duodenal enterocytes of healthy Japanese subjects.
- Published in:
- Clinical Pharmacology & Therapeutics, 2002, v. 71, n. 4, p. 297, doi. 10.1067/mcp.2002.122055
- By:
- Publication type:
- Article
Primary Levofloxacin Resistance and gyrA/B Mutations Among Helicobacter pylori in Japan.
- Published in:
- Helicobacter, 2006, v. 11, n. 4, p. 243, doi. 10.1111/j.1523-5378.2006.00415.x
- By:
- Publication type:
- Article
Impact of Helicobacter pylori Eradication Therapy on Histologic Change in the Distal Esophagus.
- Published in:
- Helicobacter, 2006, v. 11, n. 4, p. 217, doi. 10.1111/j.1523-5378.2006.00417.x
- By:
- Publication type:
- Article
Relationship Between Gastric Ulcer and Helicobacter pylori VacA Detected in Gastric Juice Using Bead-ELISA Method.
- Published in:
- Helicobacter, 2002, v. 7, n. 5, p. 281, doi. 10.1046/j.1523-5378.2002.00097.x
- By:
- Publication type:
- Article
TNFRSF1B A1466G genotype is predictive of clinical efficacy after treatment with a definitive 5-fluorouracil/cisplatin-based chemoradiotherapy in Japanese patients with esophageal squamous cell carcinoma.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2010, v. 29, p. 100, doi. 10.1186/1756-9966-29-100
- By:
- Publication type:
- Article
Quality of Life Associated with Ramucirumab Treatment in Patients with Advanced Gastric Cancer in Japan: Exploratory Analysis from the Phase III RAINBOW Trial.
- Published in:
- Clinical Drug Investigation, 2021, v. 41, n. 1, p. 53, doi. 10.1007/s40261-020-00979-3
- By:
- Publication type:
- Article
Phase II Study of Oxaliplatin in Japanese Patients with Metastatic Colorectal Cancer Refractory to Fluoropyrimidines.
- Published in:
- Japanese Journal of Clinical Oncology, 2007, v. 37, n. 6, p. 440, doi. 10.1093/jjco/hym069
- By:
- Publication type:
- Article
A Phase II Study of the Global Dose and Schedule of Capecitabine in Japanese Patients with Metastatic Colorectal Cancer.
- Published in:
- Japanese Journal of Clinical Oncology, 2006, v. 36, n. 7, p. 410, doi. 10.1093/jjco/hyl058
- By:
- Publication type:
- Article
Phase II Study of Sequential Methotrexate and 5-Fluorouracil Chemotherapy Against Peritoneally Disseminated Gastric Cancer with Malignant Ascites: a Report from the Gastrointestinal Oncology Study Group of the Japan Clinical Oncology Group, JCOG 9603 ...
- Published in:
- Japanese Journal of Clinical Oncology, 2004, v. 34, n. 6, p. 316, doi. 10.1093/jjco/hyh063
- By:
- Publication type:
- Article
Effects of a bolus injection of 5-fluorouracil on dihydropyrimidine dehydrogenase activity in rats receiving continuous infusion of 5-fluorouracil.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Phase I trial of 5-FU, docetaxel, and nedaplatin (UDON) combination therapy for recurrent or metastatic esophageal cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 76, n. 2, p. 279, doi. 10.1007/s00280-015-2799-3
- By:
- Publication type:
- Article
Pharmacokinetic analysis of capecitabine and cisplatin in combination with trastuzumab in Japanese patients with advanced HER2-positive gastric cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2012, v. 69, n. 4, p. 949, doi. 10.1007/s00280-011-1783-9
- By:
- Publication type:
- Article
DS-8201a, a new HER2-targeting antibody-drug conjugate incorporating a novel DNA topoisomerase I inhibitor, overcomes HER2-positive gastric cancer T-DM1 resistance.
- Published in:
- International Journal of Cancer, 2017, v. 141, n. 8, p. 1682, doi. 10.1002/ijc.30870
- By:
- Publication type:
- Article
Pattern of disease progression during third-line or later chemotherapy with nivolumab associated with poor prognosis in advanced gastric cancer: a multicenter retrospective study in Japan.
- Published in:
- Gastric Cancer, 2023, v. 26, n. 1, p. 132, doi. 10.1007/s10120-022-01349-y
- By:
- Publication type:
- Article
Exploration of predictors of benefit from nivolumab monotherapy for patients with pretreated advanced gastric and gastroesophageal junction cancer: post hoc subanalysis from the ATTRACTION-2 study.
- Published in:
- Gastric Cancer, 2022, v. 25, n. 1, p. 207, doi. 10.1007/s10120-021-01230-4
- By:
- Publication type:
- Article
Nivolumab in previously treated advanced gastric cancer (ATTRACTION-2): 3-year update and outcome of treatment beyond progression with nivolumab.
- Published in:
- Gastric Cancer, 2021, v. 24, n. 4, p. 946, doi. 10.1007/s10120-021-01173-w
- By:
- Publication type:
- Article
A phase 3 study of nivolumab in previously treated advanced gastric or gastroesophageal junction cancer (ATTRACTION-2): 2-year update data.
- Published in:
- Gastric Cancer, 2020, v. 23, n. 3, p. 510, doi. 10.1007/s10120-019-01034-7
- By:
- Publication type:
- Article
Exploratory subgroup analysis of patients with prior trastuzumab use in the ATTRACTION-2 trial: a randomized phase III clinical trial investigating the efficacy and safety of nivolumab in patients with advanced gastric/gastroesophageal junction cancer.
- Published in:
- Gastric Cancer, 2020, v. 23, n. 1, p. 143, doi. 10.1007/s10120-019-00970-8
- By:
- Publication type:
- Article
A subanalysis of Japanese patients in a randomized, double-blind, placebo-controlled, phase 3 trial of nivolumab for patients with advanced gastric or gastro-esophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2)
- Published in:
- Gastric Cancer, 2019, v. 22, n. 2, p. 344, doi. 10.1007/s10120-018-0899-6
- By:
- Publication type:
- Article
First-line chemotherapy with S-1 alone or S-1 plus cisplatin for elderly patients with advanced gastric cancer: a multicenter propensity score matched study.
- Published in:
- Gastric Cancer, 2018, v. 21, n. 5, p. 792, doi. 10.1007/s10120-018-0797-y
- By:
- Publication type:
- Article
Subgroup analyses of the safety and efficacy of ramucirumab in Japanese and Western patients in RAINBOW: a randomized clinical trial in second-line treatment of gastric cancer.
- Published in:
- Gastric Cancer, 2016, v. 19, n. 3, p. 927, doi. 10.1007/s10120-015-0559-z
- By:
- Publication type:
- Article
Efficacy and safety of capecitabine plus cisplatin in Japanese patients with advanced or metastatic gastric cancer: subset analyses of the AVAGAST study and the ToGA study.
- Published in:
- Gastric Cancer, 2013, v. 16, n. 2, p. 175, doi. 10.1007/s10120-012-0167-0
- By:
- Publication type:
- Article
Erratum to: Efficacy and safety of capecitabine plus cisplatin in Japanese patients with advanced or metastatic gastric cancer: subset analyses of the AVAGAST study and the ToGA study.
- Published in:
- 2013
- By:
- Publication type:
- Correction Notice
Efficacy of trastuzumab in Japanese patients with HER2-positive advanced gastric or gastroesophageal junction cancer: a subgroup analysis of the Trastuzumab for Gastric Cancer (ToGA) study.
- Published in:
- Gastric Cancer, 2012, v. 15, n. 3, p. 313, doi. 10.1007/s10120-011-0118-1
- By:
- Publication type:
- Article
Exploratory Biomarker Analysis Using Plasma Angiogenesis-Related Factors and Cell-Free DNA in the TRUSTY Study: A Randomized, Phase II/III Study of Trifluridine/Tipiracil Plus Bevacizumab as Second-Line Treatment for Metastatic Colorectal Cancer.
- Published in:
- Targeted Oncology, 2024, v. 19, n. 1, p. 59, doi. 10.1007/s11523-023-01027-8
- By:
- Publication type:
- Article
Prevention of Irinotecan-Induced Diarrhea by Oral Sodium Bicarbonate and Influence on Pharmacokinetics.
- Published in:
- Oncology, 2004, v. 67, n. 5/6, p. 327, doi. 10.1159/000082915
- By:
- Publication type:
- Article
aCGH Analysis of Predictive Biomarkers for Response to Bevacizumab plus Oxaliplatin‐ or Irinotecan‐Based Chemotherapy in Patients with Metastatic Colorectal Cancer.
- Published in:
- Oncologist, 2019, v. 24, n. 3, p. 327, doi. 10.1634/theoncologist.2018-0119
- By:
- Publication type:
- Article
Phase II Trial of 5‐Fluorouracil, Docetaxel, and Nedaplatin (UDON) Combination Therapy for Recurrent or Metastatic Esophageal Cancer.
- Published in:
- Oncologist, 2019, v. 24, n. 2, p. 163, doi. 10.1634/theoncologist.2018-0653
- By:
- Publication type:
- Article
Randomized, Open‐Label Phase II Study Comparing Capecitabine‐Cisplatin Every 3 Weeks with S‐1‐Cisplatin Every 5 Weeks in Chemotherapy‐Naïve Patients with HER2‐Negative Advanced Gastric Cancer: OGSG1105, HERBIS‐4A Trial
- Published in:
- Oncologist, 2018, v. 23, n. 12, p. 1411, doi. 10.1634/theoncologist.2018-0175
- By:
- Publication type:
- Article
Determination of Prognostic Factors in Japanese Patients With Advanced Gastric Cancer Using the Data From a Randomized Controlled Trial, Japan Clinical Oncology Group 9912.
- Published in:
- Oncologist, 2014, v. 19, n. 4, p. 358, doi. 10.1634/theoncologist.2013-0306
- By:
- Publication type:
- Article
Association between circadian and chemotherapeutic cycle effects on plasma concentration of 5-fluorouracil and the clinical outcome following definitive 5-fluorouracil/cisplatin-based chemoradiotherapy in patients with esophageal squamous cell carcinoma.
- Published in:
- Oncology Letters, 2019, v. 17, n. 1, p. 668
- By:
- Publication type:
- Article
Role of debulking surgery in combination with immune therapy: A successfully treated case of locally advanced mucosal melanoma.
- Published in:
- Molecular & Clinical Oncology, 2022, v. 16, n. 1, p. N.PAG
- By:
- Publication type:
- Article
Role of metallothionein in Helicobacter pylori-positive gastric mucosa with or without early gastric cancer and the effect on its expression after eradication therapy.
- Published in:
- Journal of Gastroenterology & Hepatology, 2008, v. 23, n. 8pt2, p. e334, doi. 10.1111/j.1440-1746.2007.05124.x
- By:
- Publication type:
- Article
Effects of Helicobacter pylori eradication therapy on gastric emptying measured using the <sup>13</sup>C-octanoic acid breath test and the acetaminophen method.
- Published in:
- Journal of Gastroenterology & Hepatology, 2006, v. 21, n. 5, p. 824, doi. 10.1111/j.1440-1746.2006.04075.x
- By:
- Publication type:
- Article